| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA769455 | A | Cytotoxic dose at which 50% growth of normal cells is inhibited | Chlorocebus sabaeus | 47 | ALA1125251 | cell-based format | Scientific Literature | |
| 2. | ALA768385 | F | Minimum drug concentration at which 99% of the polio virus is inhibited | Human enterovirus C | 39 | ALA1125251 | organism-based format | Scientific Literature | |
| 3. | ALA768389 | F | Maximal non-toxic dose (MNTD) that shows antiviral activity. | Human enterovirus C | 61 | ALA1125251 | organism-based format | Scientific Literature | |
| 4. | ALA766871 | F | The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) | Human enterovirus C | 48 | ALA1125251 | organism-based format | Scientific Literature | |
| 5. | ALA766876 | F | Minimal dose which produces titer reduction at 10 ug/mL (mD RF10e3) | Human enterovirus C | 35 | ALA1125251 | organism-based format | Scientific Literature | |
| 6. | ALA882153 | F | Cytotoxic dose at which 50% growth of normal cells is inhibited against rhino virus infection. | Human rhinovirus sp. | 28 | ALA1125251 | organism-based format | Scientific Literature | |
| 7. | ALA799318 | F | Minimum drug concentration at which 99% of the rhino virus is inhibited. | Human rhinovirus sp. | 23 | ALA1125251 | organism-based format | Scientific Literature | |
| 8. | ALA851081 | A | Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values | Human enterovirus C | 38 | ALA1125251 | organism-based format | Scientific Literature | |
| 9. | ALA4180032 | F | Cytotoxicity against human SK-MEL-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 16 | ALA4177605 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!